Antiviral Drug Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Antiviral drugs are the ones used for treating viral infections rather than bacterial ones. Antiviral drugs are of antimicrobials which include antibiotic or antiviral drugs based on monoclonal antibodies. The market is estimated to be USD 45.64 Billion by 2024 from USD 32.48 Billion in 2017 at a CAGR of 5.78%.

Global antiviral drug market share:

North America is expected to have the most significant percentage and that is due to the presence of ample opportunities for pharmaceutical companies to market the product and rise in viral infection incidences and increase in public awareness.

Global antiviral drug market size:

Technology, end user and type segment the antiviral drug market. The technology is having the most significant demand as these drugs are used for viral infections such as HIV, herpes, hepatitis and influenza while most of these are used for specific viral infections and few for broad-range of areas.

Global antiviral drug market growth:

The growth of antiviral drug market is majorly driven by an increase in public awareness, rise in healthcare expenditure, R & D development incidence of virus life-threatening diseases and rate of growth of viral infections like HIV herpes and hepatitis.

Global antiviral drug market industry analysis:

The market is classified as technology, end user and type. The technology is segmented into HIV, Hepatitis, herpes and influenza. Type is classified into branded and genetics. Here the primary market is based on the viral infections that are HIV and others.

Global antiviral drug market outlook:

Global antiviral drug market majorly deals with the medication for viral infections. Most antivirals are used for specific viral infections while a broad spectrum antiviral is effective against wide range of viruses. Most of the firms and industries are trying to develop the technologies and monitor the viral infections. The growth is predominant in North America.

Global antiviral drug market Trends:

Johnson & Johnson was offering the world’s most extensive range of consumer healthcare products.Cipla is the world’s largest manufacturer of antiviral drugs and has the products pharmaceutical ingredients to other manufacturers as well as pharmaceuticals and personal care products.

Global antiviral drug market Research reports:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Massachusetts Institute
• Abbott Healthcare
• Johnson and Johnson
• Roche Holding Ag
• Cipla
• Merck & Co